Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine

Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D. The company will now be initiating Phase III clinical trial in around 30,000 volunteers, Zydus Cadila said in a statement. ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials, it added.

source https://timesofindia.indiatimes.com/india/zydus-cadila-gets-dcgi-nod-to-initiate-phase-3-clinical-trials-for-covid-19-vaccine/articleshow/80082849.cms